Skip to main content

Table 2 Spearman correlation of TG2 and clinicopathological characteristics

From: TG2 as a novel breast cancer prognostic marker promotes cell proliferation and glycolysis by activating the MEK/ERK/LDH pathway

Characteristics

TG2 expression level

Spearman Correlation

P Value

Clinical stage

0.193

0.005

Molecular subtype

−0.161

0.020

Survival

0.230

0.001

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us